Tech Company Financing Transactions
Cambrooke Therapeutics Funding Round
Seventure Partners, Galen Partners and private investors invested in a Series C funding round for Cambrooke Therapeutics. This venture round was announced on 4/12/2016.
Transaction Overview
Company Name
Announced On
4/12/2016
Transaction Type
Venture Equity
Amount
Unknown
Round
Series C
Investors
Seventure Partners (Lead Investor) (Oxana Kukhaneva)
Proceeds Purpose
This round of financing provides us great strategic value well beyond the capital raised; I look forward to leveraging the expertise of our new investors as we continue our global expansion and entry into other disease states.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
4 Copeland Dr.
Ayer, MA 01432
USA
Ayer, MA 01432
USA
Phone
Website
Email Address
Overview
Founded in 2000, Cambrooke is a private equity-backed, Massachusetts-based therapeutic nutrition company and global provider of medical nutrition products for patients with serious chronic unmet medical needs.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Operating Officer
Howard Lossing
Co-Founder
Lynn Paolella
Browse more venture capital transactions:
Prev: 4/12/2016: Critizr venture capital transaction
Next: 4/12/2016: DocSend venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to document every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs